Mid Cap Losers: Cornerstone OnDemand (NASDAQ:CSOD), Companhia de Saneamento Basico (ADR) (NYSE:SBS), Puma Biotechnology (NYSE:PBYI), SYNNEX Corporation (NYSE:SNX)

Posted by on Apr 09, 2014

Shares of Cornerstone OnDemand (NASDAQ:CSOD) were down 7.5% during mid-day trading on Tuesday after JMP Securities lowered their price target on the stock from $70.00 to $63.00, American Banking News reports. The company traded as low as $38.33 and last traded at $40.88, with a volume of 3,682,756 shares traded. The stock had previously closed at $44.20. Cornerstone OnDemand, Inc. (NASDAQ:CSOD) shares after opening at $43.41on last trade day and at the end of the day closed at $39.85. Company price to sales ratio in past twelve months was calculated as 11.37 and price to cash ratio as 6.80. Cornerstone OnDemand, Inc. (NASDAQ:CSOD) showed a negative weekly performance of -19.54%.

Companhia de Saneamento Basico (ADR) (NYSE:SBS) said on March 27 it approved FY 2013 own capita interest payment totaling 537,464,959.85 Brazilian reais, corresponding to 0.78633094301 real per share.Ex-interest date April 8. Companhia de Saneamento Basico (ADR) (NYSE:SBS) shares fell -3.08% in last trading session and ended the day on $9.10. SBS return on equity ratio is recorded as17.60% and its return on assets is 7.80%. Companhia de Saneamento Basico (ADR) (NYSE:SBS) yearly performance is -41.02%.

Shares of Puma Biotechnology Inc (NYSE:PBYI) dropped 18 percent on Monday after the Westwood drug developer reported clinical trial results for its experimental breast cancer drug that were less dramatic than investors expected. Puma Biotechnology Inc (NYSE:PBYI) shares moved down -6.99% in last trading session and was closed at $80.86, while trading in range of $77.05 – $89.22. Puma Biotechnology Inc (NYSE:PBYI) year to date (YTD) performance is -21.90%.

Research analysts at Brean Capital raised their target price on shares of SYNNEX (NYSE:SNX) from $72.00 to $85.00 in a report released on Friday, StockRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Brean Capital’s price objective would indicate a potential upside of 14.44% from the company’s current price. SYNNEX Corporation (NYSE:SNX) weekly performance is 16.24%%. On last trading day company shares ended up $71.72. SYNNEX Corporation (NYSE:SNX) distance from 50-day simple moving average (SMA50) is 757%. Analysts mean target price for the company is $78.17.

Leave a Reply